{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:58:40Z","timestamp":1785416320867,"version":"3.56.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Health Canada\u2019s Substance Use and Addictions Program (SUAP) Grant","award":["2122-HQ-000021"],"award-info":[{"award-number":["2122-HQ-000021"]}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["FRN:181006"],"award-info":[{"award-number":["FRN:181006"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>People who use drugs (PWUD) face disproportionately high rates of hospitalizations and patient-initiated discharge (leaving against medical advice), explained by a combination of stigma, withdrawal, judgment, blame, and improper pain management. In addition, evidence has shown that despite abstinence-based policies within healthcare settings, PWUD continue to use their substances in healthcare environments often hidden away from hospital staff, resulting in fatalities. Various novel overdose detection technologies (ODTs) have been developed with early adoption in a few settings to reduce the morbidity and mortality from risky substance use patterns within healthcare environments. Our study aimed to gain the perspectives of healthcare workers across Canada on implementing ODTs within these settings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>We used purposive and snowball sampling to recruit 16 healthcare professionals to participate in semi-structured interviews completed by two evaluators. Interview transcripts were analyzed using thematic analysis to identify key themes and subthemes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Participants recognized ODTs as a potentially feasible solution for increasing the safety of PWUD in healthcare settings. Our results suggest the mixed ability of these services to decrease stigma and build rapport with PWUD. Participants further highlighted barriers to implementing these services, including pre-established policies, legal recourse, and coordination of emergency responses to suspected overdoses. Lastly, participants highlight that ODTs should only be one part of a multifaceted approach to reducing harm in healthcare settings and could currently be integrated into discharge planning.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Healthcare professionals from across Canada found ODTs to be an acceptable intervention, but only as part of a larger suite of harm reduction interventions to reduce the harms associated with illicit drug use in healthcare settings. In contrast, participants noted institutional policies, stigma on behalf of healthcare workers and leadership would present significant challenges to their uptake and dissemination.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13722-023-00433-7","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T08:02:47Z","timestamp":1705046567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Perspectives of healthcare workers on the integration of overdose detection technologies in acute care settings"],"prefix":"10.1186","volume":"19","author":[{"given":"William","family":"Rioux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Kilby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Vandenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1566-0015","authenticated-orcid":false,"given":"S. Monty","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,12]]},"reference":[{"key":"433_CR1","unstructured":"Public Health Agency of Canada. Opioid and Stimulant related Harms in Canada. 2022. https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids-stimulants\/. Accessed 4 Nov 2022."},{"key":"433_CR2","unstructured":"Opioid- and Stimulant-related Harms in Canada. https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids-stimulants\/. Accessed 4 Nov 2022."},{"issue":"6","key":"433_CR3","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/add.14892","volume":"115","author":"D Lewer","year":"2020","unstructured":"Lewer D, Freer J, King E, Larney S, Degenhardt L, Tweed EJ, et al. Frequency of health-care utilization by adults who use illicit drugs: a systematic review and meta-analysis. Addiction. 2020;115(6):1011\u201323.","journal-title":"Addiction"},{"issue":"3","key":"433_CR4","doi-asserted-by":"publisher","first-page":"074","DOI":"10.1093\/ofid\/ofaa074","volume":"7","author":"EF Eaton","year":"2020","unstructured":"Eaton EF, Westfall AO, McClesky B, Paddock CS, Lane PS, Cropsey KL, et al. In-hospital illicit drug use and patient-directed discharge: barriers to care for patients with injection-related infections. Open Forum Infect Dis. 2020;7(3):074.","journal-title":"Open Forum Infect Dis"},{"key":"433_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jsat.2018.06.011","volume":"92","author":"LC Fanucchi","year":"2018","unstructured":"Fanucchi LC, Lofwall MR, Nuzzo PA, Walsh SL. In-hospital illicit drug use, substance use disorders, and acceptance of residential treatment in a prospective pilot needs assessment of hospitalized adults with severe infections from injecting drugs. J Subst Abuse Treat. 2018;92:64\u20139.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"433_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1155\/2015\/868746","volume":"20","author":"L Ti","year":"2015","unstructured":"Ti L, Voon P, Dobrer S, Montaner J, Wood E, Kerr T. Denial of pain medication by health care providers predicts in-hospital illicit drug use among individuals who use illicit drugs. Pain Res Manag. 2015;20(2):84\u20138.","journal-title":"Pain Res Manag"},{"issue":"5","key":"433_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/dar.12270","volume":"34","author":"HK Grewal","year":"2015","unstructured":"Grewal HK, Ti L, Hayashi K, Dobrer S, Wood E, Kerr T. Illicit drug use in acute care settings. Drug Alcohol Rev. 2015;34(5):499\u2013502.","journal-title":"Drug Alcohol Rev"},{"issue":"5","key":"433_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/jhm.2344","volume":"10","author":"L Ti","year":"2015","unstructured":"Ti L, Buxton J, Harrison S, Dobrer S, Montaner J, Wood E, et al. Willingness to access an in-hospital supervised injection facility among hospitalized people who use illicit drugs: in-hospital SIF. J Hosp Med. 2015;10(5):301\u20136.","journal-title":"J Hosp Med"},{"issue":"1","key":"433_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12954-022-00594-9","volume":"19","author":"R Perera","year":"2022","unstructured":"Perera R, Stephan L, Appa A, Giuliano R, Hoffman R, Lum P, et al. Meeting people where they are: implementing hospital-based substance use harm reduction. Harm Reduct J. 2022;19(1):14.","journal-title":"Harm Reduct J"},{"issue":"9","key":"433_CR10","doi-asserted-by":"publisher","first-page":"e2484","DOI":"10.1093\/cid\/ciaa1126","volume":"73","author":"SD Kimmel","year":"2021","unstructured":"Kimmel SD, Kim JH, Kalesan B, Samet JH, Walley AY, Larochelle MR. Against medical advice discharges in injection and non-injection drug use-associated infective endocarditis: a nationwide cohort study. Clin Infect Dis. 2021;73(9):e2484\u201392.","journal-title":"Clin Infect Dis"},{"key":"433_CR11","doi-asserted-by":"publisher","first-page":"103206","DOI":"10.1016\/j.drugpo.2021.103206","volume":"94","author":"RA Pollini","year":"2021","unstructured":"Pollini RA, Paquette CE, Drvar T, Marshalek P, Ang-Rabanes M, Feinberg J, et al. A qualitative assessment of discharge against medical advice among patients hospitalized for injection-related bacterial infections in West Virginia. Int J Drug Policy. 2021;94:103206.","journal-title":"Int J Drug Policy"},{"key":"433_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.socscimed.2014.01.010","volume":"105","author":"R McNeil","year":"2014","unstructured":"McNeil R, Small W, Wood E, Kerr T. Hospitals as a \u2018risk environment\u2019: an ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs. Soc Sci Med. 2014;105:59\u201366.","journal-title":"Soc Sci Med"},{"issue":"1","key":"433_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12954-022-00596-7","volume":"19","author":"E Dogherty","year":"2022","unstructured":"Dogherty E, Patterson C, Gagnon M, Harrison S, Chase J, Boerstler J, et al. Implementation of a nurse-led overdose prevention site in a hospital setting: lessons learned from St. Paul\u2019s Hospital, Vancouver, Canada. Harm Reduct J. 2022;19(1):13.","journal-title":"Harm Reduct J"},{"issue":"18","key":"433_CR14","doi-asserted-by":"publisher","first-page":"E476","DOI":"10.1503\/cmaj.191365","volume":"192","author":"KA Dong","year":"2020","unstructured":"Dong KA, Brouwer J, Johnston C, Hyshka E. Supervised consumption services for acute care hospital patients. Can Med Assoc J. 2020;192(18):E476\u20139.","journal-title":"Can Med Assoc J"},{"key":"433_CR15","doi-asserted-by":"publisher","first-page":"109608","DOI":"10.1016\/j.drugalcdep.2022.109608","volume":"239","author":"S Nolan","year":"2022","unstructured":"Nolan S, Kelian S, Kerr T, Young S, Malmgren I, Ghafari C, et al. Harm reduction in the hospital: an overdose prevention site (OPS) at a Canadian hospital. Drug Alcohol Depend. 2022;239:109608.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"433_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12954-022-00712-7","volume":"19","author":"R Cassie","year":"2022","unstructured":"Cassie R, Hayashi K, DeBeck K, Milloy MJ, Cui Z, Strike C, et al. Difficulty accessing supervised consumption services during the COVID-19 pandemic among people who use drugs in Vancouver, Canada. Harm Reduct J. 2022;19(1):126.","journal-title":"Harm Reduct J"},{"key":"433_CR17","doi-asserted-by":"publisher","first-page":"103038","DOI":"10.1016\/j.drugpo.2020.103038","volume":"88","author":"BM Buchheit","year":"2021","unstructured":"Buchheit BM, Crable EL, Lipson SK, Drainoni ML, Walley AY. Opening the door to somebody who has a chance\u2014The experiences and perceptions of public safety personnel towards a public restroom overdose prevention alarm system. Int J Drug Policy. 2021;88:103038.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"433_CR18","doi-asserted-by":"publisher","first-page":"e0283549","DOI":"10.1371\/journal.pone.0283549","volume":"18","author":"D Lewer","year":"2023","unstructured":"Lewer D, Brothers TD, Harris M, Rock KL, Copeland CS. Opioid-related deaths during hospital admissions or shortly after discharge in the United Kingdom: a thematic framework analysis of coroner reports. PLoS ONE. 2023;18(4):e0283549.","journal-title":"PLoS ONE"},{"issue":"2","key":"433_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/1753-6405.12032","volume":"37","author":"MM Islam","year":"2013","unstructured":"Islam MM, Topp L, Iversen J, Day C, Conigrave KM, Maher L. Healthcare utilisation and disclosure of injecting drug use among clients of Australia\u2019s needle and syringe programs. Aust N Z J Public Health. 2013;37(2):148\u201354.","journal-title":"Aust N Z J Public Health"},{"key":"433_CR20","unstructured":"National Overdose Response Service (NORS). National Overdose Response Service (NORS). https:\/\/www.nors.ca. Accessed 24 Oct 2022."},{"key":"433_CR21","unstructured":"Never Use Alone Inc. \u2013 800-484-3731. https:\/\/neverusealone.com\/. Accessed 25 Oct 2022."},{"issue":"2","key":"433_CR22","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3390\/ijerph20021230","volume":"20","author":"AR Lombardi","year":"2023","unstructured":"Lombardi AR, Arya R, Rosen JG, Thompson E, Welwean R, Tardif J, et al. Overdose detection technologies to reduce solitary overdose deaths: a literature review. Int J Environ Res Public Health. 2023;20(2):1230.","journal-title":"Int J Environ Res Public Health"},{"issue":"250","key":"433_CR23","doi-asserted-by":"publisher","first-page":"110878","DOI":"10.1016\/j.drugalcdep.2023.110878","volume":"1","author":"A Loverock","year":"2023","unstructured":"Loverock A, Marshall T, Viste D, Safi F, Rioux W, Sedaghat N, et al. Electronic harm reduction interventions for drug overdose monitoring and prevention: a scoping review. Drug Alcohol Depend. 2023;1(250):110878.","journal-title":"Drug Alcohol Depend"},{"issue":"25","key":"433_CR24","doi-asserted-by":"publisher","first-page":"e40389","DOI":"10.2196\/40389","volume":"15","author":"A Oteo","year":"2023","unstructured":"Oteo A, Daneshvar H, Baldacchino A, Matheson C. Overdose alert and response technologies: state-of-the-art review. J Med Internet Res. 2023;15(25):e40389.","journal-title":"J Med Internet Res"},{"key":"433_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000870","author":"J Tay Wee Teck","year":"2023","unstructured":"Tay Wee Teck J, Oteo A, Baldacchino A. Rapid opioid overdose response system technologies. Curr Opin Psychiatry. 2023. https:\/\/doi.org\/10.1097\/YCO.0000000000000870.","journal-title":"Curr Opin Psychiatry"},{"issue":"46","key":"433_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1503\/cmaj.220579","volume":"194","author":"G Matskiv","year":"2022","unstructured":"Matskiv G, Marshall T, Krieg O, Viste D, Ghosh SM. Virtual overdose monitoring services: a novel adjunctive harm reduction approach for addressing the overdose crisis. CMAJ. 2022;194(46):5.","journal-title":"CMAJ"},{"issue":"1","key":"433_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-023-16751-z","volume":"23","author":"D Viste","year":"2023","unstructured":"Viste D, Rioux W, Cristall N, Orr T, Taplay P, Morris-Miller L, et al. Association of drug overdoses and user characteristics of Canada\u2019s national mobile\/virtual overdose response hotline: the national overdose response service (NORS). BMC Public Health. 2023;23(1):1\u201312.","journal-title":"BMC Public Health"},{"issue":"11","key":"433_CR28","doi-asserted-by":"publisher","first-page":"1242795","DOI":"10.3389\/fpubh.2023.1242795","volume":"19","author":"W Rioux","year":"2023","unstructured":"Rioux W, Enns B, Ghosh SM. Virtual overdose monitoring services\/mobile overdose response services: estimated number of potentially averted drug poisoning fatality events by various telephone and digital-based overdose prevention\/harm reduction services in North America. Front Public Health. 2023;19(11):1242795.","journal-title":"Front Public Health"},{"issue":"2","key":"433_CR29","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/dar.13373","volume":"41","author":"J Draanen","year":"2022","unstructured":"Draanen J, Satti S, Morgan J, Gaudette L, Knight R, Ti L. Using passive surveillance technology for overdose prevention: key ethical and implementation issues. Drug Alcohol Rev. 2022;41(2):406\u20139.","journal-title":"Drug Alcohol Rev"},{"key":"433_CR30","unstructured":"CityNews Vancouver. 2023. Nanaimo hospital installs washroom sensors. https:\/\/vancouver.citynews.ca\/2023\/03\/16\/nanaimo-hospital-toxic-drug-sensor\/. Accessed 24 May 2023."},{"key":"433_CR31","unstructured":"The Brave App. The Brave App. https:\/\/www.thebraveapp.com. Accessed 24 Oct 2022."},{"key":"433_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-019-05311-0","author":"D Collins","year":"2019","unstructured":"Collins D, Alla J, Nicolaidis C, Gregg J, Gullickson DJ, Patten A, et al. \u201cIf it wasn\u2019t for him, i wouldn\u2019t have talked to them\u201d: qualitative study of addiction peer mentorship in the hospital. J Gen Intern Med. 2019. https:\/\/doi.org\/10.1007\/s11606-019-05311-0.","journal-title":"J Gen Intern Med"},{"key":"433_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2016.01.003","volume":"63","author":"EL Bassuk","year":"2016","unstructured":"Bassuk EL, Hanson J, Greene RN, Richard M, Laudet A. Peer-delivered recovery support services for addictions in the United States: a systematic review. J Subst Abuse Treat. 2016;63:1\u20139.","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"433_CR34","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1080\/10826084.2021.2023187","volume":"57","author":"C Ramdin","year":"2022","unstructured":"Ramdin C, Guo M, Fabricant S, Santos C, Nelson L. The impact of a peer-navigator program on naloxone distribution and buprenorphine utilization in the emergency department. Subst Use Misuse. 2022;57(4):581\u20137.","journal-title":"Subst Use Misuse"},{"issue":"1","key":"433_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/ADM.0000000000000536","volume":"14","author":"I Danovitch","year":"2020","unstructured":"Danovitch I, Vanle B, Van Groningen N, Ishak W, Nuckols T. Opioid overdose in the hospital setting: a systematic review. J Addict Med. 2020;14(1):39\u201347.","journal-title":"J Addict Med"},{"issue":"10","key":"433_CR36","doi-asserted-by":"publisher","first-page":"1003759","DOI":"10.1371\/journal.pmed.1003759","volume":"18","author":"D Lewer","year":"2021","unstructured":"Lewer D, Eastwood B, White M, Brothers TD, McCusker M, Copeland C, et al. Fatal opioid overdoses during and shortly after hospital admissions in England: a case-crossover study. PLOS Med. 2021;18(10):1003759.","journal-title":"PLOS Med"},{"issue":"6","key":"433_CR37","first-page":"1712","volume":"1","author":"J Moe","year":"2020","unstructured":"Moe J, Badke K, Pratt M, Cho RY, Azar P, Flemming H, et al. Microdosing and standard-dosing take-home buprenorphine from the emergency department: a feasibility study. J Am Coll Emerg Phys Open. 2020;1(6):1712\u201322.","journal-title":"J Am Coll Emerg Phys Open"},{"issue":"3","key":"433_CR38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1080\/08897077.2019.1680479","volume":"42","author":"VWL Tsang","year":"2021","unstructured":"Tsang VWL, Papamihali K, Crabtree A, Buxton JA. Acceptability of technological solutions for overdose monitoring: Perspectives of people who use drugs. Subst Abuse. 2021;42(3):284\u201393.","journal-title":"Subst Abuse"},{"issue":"4","key":"433_CR39","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/dar.13645","volume":"42","author":"B Tas","year":"2023","unstructured":"Tas B, Lawn W, Traykova EV, Evans RAS, Murvai B, Walker H, et al. A scoping review of mHealth technologies for opioid overdose prevention, detection and response. Drug Alcohol Rev. 2023;42(4):748\u201364.","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"433_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10597-022-00982-2","volume":"59","author":"JN Mullen","year":"2023","unstructured":"Mullen JN, Levitt A, Markoulakis R. Supporting individuals with mental health and\/or addictions issues through patient navigation: a scoping review. Community Ment Health J. 2023;59(1):35\u201356.","journal-title":"Community Ment Health J"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-023-00433-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-023-00433-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-023-00433-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T08:08:02Z","timestamp":1705046882000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-023-00433-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,12]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["433"],"URL":"https:\/\/doi.org\/10.1186\/s13722-023-00433-7","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,12]]},"assertion":[{"value":"5 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted as part of a quality improvement project and received ethical approval from the University of Calgary Conjoint Health Research Ethics Board (REB21-1655).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"M.G. co-founded NORS and belongs to the Canadian Society of Addiction Medicine and has no personal financial conflicts of interest to disclose. The results of this work may be used to apply for funding for NORS or to make operational changes to NORS. The rest of the authors are unaffiliated with any other ODTs or NORS in particular and have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}